Global X Data Center & Digital Infra ETF vs State Street SPDR S&P Biotech ETF — how do they compare? Global X Data Center & Digital Infra ETF trades at $27.65 (market cap $2.04B), while State Street SPDR S&P Biotech ETF trades at $153.7 (market cap $10.11B). The key difference: State Street SPDR S&P Biotech ETF is far larger — about 5× Global X Data Center & Digital Infra ETF's market cap, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Global X Data Center & Digital Infra ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Global X Data Center & Digital Infra ETF for 15 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| DTCR | XBI | |
|---|---|---|
Market Cap | $2.04B | $10.11B |
Volume | 899,532 | 12,903,266 |
Sector | Sector/Thematic | Broad Market / Factor |
52-Week High | $32.46 | $169.55 |
52-Week Low | $19.73 | $104.99 |
Typical Hold Time | 15 Days | 38 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XBI trades at $153.75, up 2.34% today, but technical indicators signal a bearish trend with resistance at $154. The ETF's modified equal-weight structure provides exposure to over 150 biotech companies, benefiting from M&A activity and positive clinical catalysts like the Merck-Moderna cancer vaccine breakthrough.
Outlook remains mixed with 100% analyst hold rating contrasting with bullish news catalysts. Key risks include high volatility, sector-specific regulatory pressures, and expense ratios higher than broader healthcare ETFs. The current technical setup near resistance requires monitoring for breakout confirmation.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Global X Data Center & Digital Infrastructure ETF seeks exposure to companies involved in data centers and digital infrastructure. Its holdings span areas such as digital infrastructure, networking, and related real estate.
Read more on DTCR →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →